TheraNews Logo

BrainsWay Announces FDA Approval of Neurolief's ProlivTMRx Neuromodulation System for Major Depressive Disorder (MDD)

benzinga|1/13/2026|depression
Share this article:
Email

BrainsWay Announces FDA Approval of Neurolief's ProlivTMRx Neuromodulation System for Major Depressive Disorder (MDD)

ONLY AVAILABLE IN PAID PLANS.


Originally reported by benzinga. Read more

Share this article:
Email

Related Articles

More stories about depression